T&L Co Ltd
KOSDAQ:340570
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
T&L Co Ltd
Deferred Income Tax
T&L Co Ltd
Deferred Income Tax Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Deferred Income Tax | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Deferred Income Tax
₩412.4m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Deferred Income Tax
₩5.6B
|
CAGR 3-Years
46%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-5%
|
|
|
SD Biosensor Inc
KRX:137310
|
Deferred Income Tax
₩127.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Deferred Income Tax
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Deferred Income Tax
₩12.7B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-11%
|
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Deferred Income Tax
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T&L Co Ltd
Glance View
T&L Co., Ltd. develops medical polymer material products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2020-11-20. The firm's main products include wound treatment materials, orthopedic fixing materials, structural adhesives, and water repellents. The wound treatment materials include products such as hydrocolloids, foams, and hydrogels as wetting dressing agents necessary for wound healing. The orthopedic fixture materials include medical devices used for the treatment and correction of fractures such as casts and splints. The firm sells its products in domestic and overseas markets such as the United States, Germany, China, and Dubai.
See Also
What is T&L Co Ltd's Deferred Income Tax?
Deferred Income Tax
412.4m
KRW
Based on the financial report for Dec 31, 2024, T&L Co Ltd's Deferred Income Tax amounts to 412.4m KRW.
What is T&L Co Ltd's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 5Y
-8%
Over the last year, the Deferred Income Tax growth was -30%. The average annual Deferred Income Tax growth rates for T&L Co Ltd have been -12% over the past three years , -8% over the past five years .
